Establishing a Cancer Genetics Programme in Asia - the Singapore Experience

Por Chieng, Wei-Shieng, Lee, Soo-Chin
Publicado em 2006

Mechanisms of Resistance to Trastuzumab and Novel Therapeutic Strategies in HER2-Positive Breast Cancer

Por Wong, Andrea L. A., Lee, Soo-Chin
Publicado em 2012

Cancer physicians’ attitude towards treatment of the elderly cancer patient in a developed Asian country

Por Pang, Angela, Ho, Shirlynn, Lee, Soo-Chin
Publicado em 2013

Precision medicine in early breast cancer—can this apply to radiotherapy?

Por Ow, Samuel G. W., Lee, Soo-Chin
Publicado no J Thorac Dis (2016)

Pseudo-Spikes Are Common in Histologically Benign Lymphoid Tissues

Por Lee, Soo-Chin, Berg, Karin D., Racke, Frederick K., Griffin, Constance A., Eshleman, James R.
Publicado em 2000

Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway

Por Wang, Tingting, Seah, Serena, Loh, Xinyi, Chan, Ching-Wan, Hartman, Mikael, Goh, Boon-Cher, Lee, Soo-Chin
Publicado no Oncotarget (2015)

UGT1A6 Polymorphisms Modulated Lung Cancer Risk in a Chinese Population

Por Kua, Ley-Fang, Ross, Soo, Lee, Soo-Chin, Mimura, Kousaku, Kono, Koji, Goh, Boon-Cher, Yong, Wei-Peng
Publicado em 2012

Influence of APOE genotypes and VKORC1 haplotypes on warfarin dose requirements in Asian patients

Por Lal, Suman, Sandanaraj, Edwin, Jada, Srinivasa Rao, Kong, Ming-Chai, Lee, Lai-Heng, Goh, Boon-Cher, Lee, Soo-Chin, Chowbay, Balram
Publicado em 2008

Liquid biopsy and therapeutic response: Circulating tumor cell cultures for evaluation of anticancer treatment

Por Khoo, Bee Luan, Grenci, Gianluca, Jing, Tengyang, Lim, Ying Bena, Lee, Soo Chin, Thiery, Jean Paul, Han, Jongyoon, Lim, Chwee Teck
Publicado no Sci Adv (2016)

Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy

Por Khoo, Bee Luan, Lee, Soo Chin, Kumar, Prashant, Tan, Tuan Zea, Warkiani, Majid Ebrahimi, Ow, Samuel GW., Nandi, Sayantani, Lim, Chwee Teck, Thiery, Jean Paul
Publicado no Oncotarget (2015)

High-Throughput Mutation Profiling Changes before and 3 Weeks after Chemotherapy in Newly Diagnosed Breast Cancer Patients

Por Tan, Sing-Huang, Sapari, Nur Sabrina, Miao, Hui, Hartman, Mikael, Loh, Marie, Chng, Wee-Joo, Iau, Philip, Buhari, Shaik Ahmad, Soong, Richie, Lee, Soo-Chin
Publicado no PLoS One (2015)

Does the Axillary Lymph Node Ratio Have Any Added Prognostic Value over pN Staging for South East Asian Breast Cancer Patients?

Por Saxena, Nakul, Hartman, Mikael, Yip, Cheng-Har, Bhoo-Pathy, Nirmala, Khin, Lay Wai, Taib, Nur Aishah, Looi, Lai-Meng, Lim, Siew-Eng, Lee, Soo-Chin, Verkooijen, Helena M.
Publicado em 2012

High expression of intratumoral stromal proteins is associated with chemotherapy resistance in breast cancer

Por Wang, Tingting, Srivastava, Supriya, Hartman, Mikael, Buhari, Shaik Ahmad, Chan, Ching-Wan, Iau, Philip, Khin, Lay Wai, Wong, Andrea, Tan, Sing-Huang, Goh, Boon-Cher, Lee, Soo-Chin
Publicado no Oncotarget (2016)

Validation of a Rapid and Sensitive LC-MS/MS Method for Determination of Exemestane and Its Metabolites, 17β-Hydroxyexemestane and 17β-Hydroxyexemestane-17-O-β-D-Glucuronide: Appli...

Por Wang, Ling-Zhi, Goh, Sok-Hwei, Wong, Andrea Li-Ann, Thuya, Win-Lwin, Lau, Jie-Ying Amelia, Wan, Seow-Ching, Lee, Soo-Chin, Ho, Paul C., Goh, Boon-Cher
Publicado no PLoS One (2015)

Validation of the CancerMath prognostic tool for breast cancer in Southeast Asia

Por Miao, Hui, Hartman, Mikael, Verkooijen, Helena M., Taib, Nur Aishah, Wong, Hoong-Seam, Subramaniam, Shridevi, Yip, Cheng-Har, Tan, Ern-Yu, Chan, Patrick, Lee, Soo-Chin, Bhoo-Pathy, Nirmala
Publicado no BMC Cancer (2016)

Ethnic Differences in Survival after Breast Cancer in South East Asia

Por Bhoo-Pathy, Nirmala, Hartman, Mikael, Yip, Cheng-Har, Saxena, Nakul, Taib, Nur Aishah, Lim, Siew-Eng, Iau, Philip, Adami, Hans-Olov, Bulgiba, Awang M., Lee, Soo-Chin, Verkooijen, Helena M.
Publicado em 2012

Dose modifications in Asian cancer patients with hepatic dysfunction receiving weekly docetaxel: A prospective pharmacokinetic and safety study

Por Syn, Nicholas Li‐Xun, Wang, Lingzhi, Wong, Andrea Li‐Ann, Soe, Mu‐Yar, Chuah, Benjamin, Chan, Daniel, Tan, Sing‐Huang, Soo, Ross Andrew, Lee, Soo‐Chin, Goh, Boon‐Cher, Yong, Wei‐Peng
Publicado no Cancer Sci (2016)

Correlation of aldo-ketoreductase (AKR) 1C3 genetic variant with doxorubicin pharmacodynamics in Asian breast cancer patients

Por Voon, Pei Jye, Yap, Hui Ling, Ma, Cho-Yee-Thu, Lu, Fan, Wong, Andrea L A, Sapari, Nur Sabrina, Soong, Richie, Soh, Thomas I P, Goh, Boon-Cher, Lee, How-Sung, Lee, Soo-Chin
Publicado em 2013

Phase 1B/2 study of the HSP90 inhibitor AUY922 plus trastuzumab in metastatic HER2-positive breast cancer patients who have progressed on trastuzumab-based regimen

Por Kong, Anthony, Rea, Daniel, Ahmed, Samreen, Beck, J. Thaddeus, López, Rafael López, Biganzoli, Laura, Armstrong, Anne C., Aglietta, Massimo, Alba, Emilio, Campone, Mario, Schmitz, Shu-Fang Hsu, Lefebvre, Caroline, Akimov, Mikhail, Lee, Soo-Chin
Publicado no Oncotarget (2016)

SPHK1 regulates proliferation and survival responses in triple-negative breast cancer

Por Datta, Arpita, Loo, Ser Yue, Huang, Baohua, Wong, Lingkai, Tan, Sheryl S.L., Tan, Tuan Zea, Lee, Soo-Chin, Thiery, Jean Paul, Lim, Yaw Chyn, Yong, Wei Peng, Lam, Yulin, Kumar, Alan Prem, Yap, Celestial T.
Publicado em 2014